Getting peptide vaccines to work: just a matter of quality control?
Celis
Esteban
E
Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA. celis@mayo.edu
D000941:Antigens / Q000276:immunology* / Q000378:metabolism; D019496:Cancer Vaccines / Q000276:immunology*; D000939:Epitopes / Q000276:immunology*; D005805:Genes, MHC Class I; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D010455:Peptides / Q000276:immunology* / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism; D022223:Vaccines, Subunit / Q000737:chemistry / Q000235:genetics / Q000276:immunology*
D000941:Antigens; D019496:Cancer Vaccines; D000939:Epitopes; D010455:Peptides; D022223:Vaccines, Subunit